{"id":447972,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2017-06-23] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T15:43:53.729000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-15.html?wbdisable=false","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions [2017-06-23] June 23, 2017 Our file number: 17-106422-736 The purpose of this Notice of Amendment is to notify the additions of Lixisenatide, Ozenoxacin and Reslizumab to the Human and Veterinary Prescription Drug Lists…","rawSnapshotUrl":"/api/snapshots/raw/447972","browseUrl":"https://replay.healtharchive.ca/job-6/20260103154353/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-15.html?wbdisable=false#ha_snapshot=447972","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}